Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer

Cancer Investigation

Volumn 23, Issue 4, 2005, Pages 338-351

  Goldstein, Mitchell J ^a,b   Mitchell, Edith Peterson ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; INTERCELLULAR ADHESION MOLECULE 1; IRINOTECAN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN; PERTECHNETIC ACID TC 99M; TUMOR MARKER;

ADJUVANT CHEMOTHERAPY; ANTIGEN FUNCTION; ANTIGEN STRUCTURE; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER IMMUNOTHERAPY; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CIGARETTE SMOKING; CLINICAL TRIAL; COLORECTAL CANCER; CRYOTHERAPY; FOLLOW UP; HUMAN; IMMUNOCYTOCHEMISTRY; INTESTINE OBSTRUCTION; LIVER DISEASE; LIVER RESECTION; LUNG METASTASIS; META ANALYSIS; MULTIGENE FAMILY; NONHUMAN; PLOIDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; REVIEW; SYSTEMATIC REVIEW; TUMOR RECURRENCE; BLOOD; COLORECTAL TUMOR; IMMUNOHISTOCHEMISTRY; PATHOLOGY; TREATMENT OUTCOME;

CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM STAGING; PROGNOSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 24744451447     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1081/CNV-58878     Document Type: Review

References (181)

1. Hosteller, R.B.; Augustus, L.B.; Mankarious, R.; Chi, K.F.; Fan, D.; Toth, C.; Thomas, P.; Jessup, J.M. Carcinoembyonic antigen as a selective enhancer of colorectal cancer metastases. J. Natl. Cancer Inst. 1990, 82, 380-385.
2. Fletcher, R.H. Carcinoembryonic antigen. Ann. Intern. Med. 1986, 104, 66.
3. Duffy, M.J. CEA as a marker for colorectal cancer: is it clinically useful? Clin. Chem. 2001, 47 (4), 624-630.
4. Thompson, J.A.; Paude, H.; Paxton, R.J.; Shively, L.; Padma, A.; Simmer, R.L.; Todd, C.W.; Riggs, A.D.; Shively, J.E. Molecular cloning of a gene belonging to the Carcinoembryonic antigen family and dissension of a domain model. Proc. Natl. Acad. Sci. U. S. A. 1987, 84 (9), 2965-2969.
5. Zimmerman, W.; Weber, B.; Ortlieb, B.; Rudert, F.; Schempp, W.; Fiebig, H.H.; Shively, J.F.; von Kleist, S.; Thompson, J.A. Chromosome localization of the Carcinoembryonic antigen gene family and differential expression in various tumors. Cancer Res. 1987, 48 (9), 2550-2554.
6. Zimmerman, W.; Ortlieb, B.; Frederick, R.; von Kleist, S. Isolation and characterization of cDNA clones encoding the human Carcinoembryonic antigen reveal a highly conserved repeating structure. Proc. Natl. Acad. Sci. U. S. A. 1987, 84 (9), 2960-2964.
7. Fuks, A.; Banjo, C.; Shuster, J.; Freedman, S.O.; Gold, P. Carcinoembryonic antigen (CEA): molecular biology and clinical significance. Biochem. Biophys. Acta 1975, 417 (2), 123-152.
8. Gold, P.; Shuster, J.; Freedman, S.O. Carcinoembryonic antigen (CEA) in clinical medicine. Cancer 1978, 42, 1399.
9. Fleisher, M.; Nisselbaum, J.S.; Loftin, L.; Smith, C.; Schwanz, M.K. Roche RIA and Abbott EIA Carcinoembryonic antigen assays compared. Clin. Chem. 1984, 30 (2), 200-205.
10. Adams, W.J.; Morris, D.L. Carcinoembryonic antigen in the evaluation of therapy of primary and metastatic colorectal cancer. Aust. N. Z. J. Surg. 1996, 66, 515-519.
11. Koness, J.K. CEA: is it of value in colorectal cancer? Rhode Isl. Med. 1995, 78, 164-166.
12. Benchimol, S.; Fuks, A.; Jothy, S.; Beauchemin, N.; Shirota, K.; Stanners, C.P. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 1989, 57 (2), 327-334.
13. Kammerer, R.; von Kleist, S. CEA expression of colorectal adenocarcinomas is correlated with their resistance against LAK-Cell lysis. Int. J. Cancer 1994, 57, 341-347.
14. Wagner, H.; Toth, C.; Steele, G.; Thomas, P. Metastatic potential of human colon cancer cells: relationship to cellular differentiation and Carcinoembryonic antigen production. Clin. Exp. Metastasis 1992, 10, 25-31.
15. Cutait, R.; Alves, V.A.; Lopes, L.C.; Cutait, D.E.; Borges, J.L.; Singer, J.; da Suva, J.H.; Goff, F.S. Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis. Colon Rectum 1991, 34 (10), 917-920.
16. Zeng, Z.; Cohen, A.M.; Urmache, R.C. Usefulness of Carcinoembryonic antigen monitoring despite normal preoperative values in node-positive colon cancer patients. Dis. Colon Rectum 1993, 36, 1063-1068.
17. Nakane, P.K.; Watanabe, T. Distribution of oncodevelopmental markers in neoplastic cells: therapeutic implications. J. Histochem. Cytochem. 1984, 32 (8), 894-898.
18. O'Brien, M.J.; Zamcheck, N.; Burke, B.; Kirkham, S.E.; Saravis, C.A.; Gottlieb, L.S. Immunocytochemical localization of carcinoembryonic antigen in benign and malignant colorectal tissues: assessment of diagnostic value. Am. J. Clin. Pathol. 1981, 75 (3), 283-290.
19. Denk, G.; Tappeiner, G.; Eckerstorfer, R. Carcinoembryonic antigen (CEA) in gastrointestinal and extragastrointestinal tumors and its relationship to tumor cell differentiation. Int. J. Cancer 1972, 10, 262-272.
20. von Kleist, S.; Chavanel, G.; Burtin, P. Identification of a normal antigen that cross reacts with the carcinoembryonic antigen (CEA). Proc. Natl. Acad. Sci. U. S. A. 1972, 69, 5492.
21. Turberville, C.; Darcy, D.A.; Laurence, D.J.; Johns, E.W.; Neville, A.M. Studies on carcinoembryonic antigen (CEA) and a related glycoprotein, CCA-2: preparation and chemical characterization. Immunochemistry 1973, 10 (12), 841-843.
22. Newman, E.S.; Petras, S.E.; Hamilton, J.G.; Georgiadis, A.; Hansen, H.J. Proceedings: interrelationship of carcinoembryonic antigen and colon carcinoma antigcn-3. Cancer Res. 1974, 34 (8), 2125-2130.
23. Tobioka, H.; Isomura, H.; Kokai, Y.; Sawada, N. Polarized distribution of CEA is associated with a tight junction molecule in human colorectal adenocarcinoma. J. Pathol. 2002, 198 (2), 207-212.
24. Schwartz, M.K. Cancer markers. In Cancer: Principles and Practice of Oncology; Devita, V.T., Ed.; Lippincott: Philadelphia, PA, 1993; 531-542.
25. Goslin, R.; Steele, G.; MacIntyre, J.; Mayer, R.; Sugarbaker, P.; Cleghorn, K.; Wilson, R.; Zamcheck, N. The use of preoperative plasma CEA levels for the stratification of patients after curative resection of colorectal cancers. Ann. Surg. 1980, 192 (6), 747-751.
26. Rutanen, E.M.; Lindgren, J.; Sipponen, P.; Stenman, V.P.; Saksela, E.; Seppala, M. Carcinoembryonic antigen in malignant and nonmalignant gynecologic tumors. Cancer 1978, 42, 581-590.
27. Ng, I.O.; Ho, J.; Pritchett, C.J.; Chan, E.Y.; Ho, F.C. CEA tissue staining in colorectal cancer patients-correlation with plasma CEA, histology staging. Pathology 1993, 23, 219-222.
28. Alexander, J.C.; Silverman, N.A.; Chretian, P.B. Effect of age and cigarette smoking carcinoembryonic antigen levels. JAMA 1976, 235, 1975-1979.
29. Bates, S.E.; Longo, D.L. Use of serum tumor markers in cancer diagnosis and management. Semin. Oncol. 1987, 14, 102.
30. Goldenberg, D.M.; Sharkey, R.M.; Primus, F.J. Carcinoembryonic antigen in histopathology: immunoperoxidase staining of conventional tissue sections. J. Natl. Cancer lnst. 1976, 57, 11-22.
31. Liu, Y.S.; Tobias, R.J.; Zurawski, V.R., Jr. A more specific, simpler radioimmunoassay for carcinoembryonic antigen, with use of monoclonal antibodies. Clin. Chem. 1985, 31, 191-195.
32. Shuster, J.; Freedman, S.O.; Gold, P. Oncofetal antigens: increasing the specificity of the CEA radioimmunoassay. Am. J. Clin. Pathol. 1977, 68 (Suppl. 5), 679-687.
33. Zucchelli, G.C.; Pilo, A.; Chiesa, M.R.; Masini, S.; Baccini, C. Minimizing between-kit variability in immunoassay for carcinoembryonic antigen by use of a common standard. Clin. Chem. 1986, 32, 1942-1943.
34. Scapa, E.; Haagensen, D.E., Jr.; Cantarow, W.; Lowenstein, M.S.; Thomas, P.; Zamchek, N. Differences in CEA values determined by EIA and RIA in patients with benign and malignant biliary obstructions. Am. J. Clin. Pathol. 1985, 83, 589-593.
35. Felder, R.; MacMillan, R.H., III; Bruns, D.C. Two monoclonal-based assays for carcinoembryonic antigen compared. Clin. Chem. 1987, 33, 700-704.
36. Tabuchi, Y.; Deguchi, H.; Imanishi, K. Comparison of carcinoembryonic antigen levels between portal and peripheral blood in patients with colorectal cancer: correlation with histopathological variables. Cancer 1987, 59, 1283-1288.
37. Garcia, A.A.; Florentine, B.D.; Simon, A.J.; Skinner, E.C.; Leichman, L.W. Xanthogranulomatous cystitis as a cause of elevated carcinoembryonic antigen mimicking recurrent colorectal cancer. Report of a case. Dis. Colon Rectum 1996, 39 (9), 1051-1054.
38. Moertel, C.G.; Fleming, T.R.; MacDonald, J.S.; Malier, D.G.; Laurie, J.A.; Tangen, C. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancers. JAMA 1993, 270 (8), 943-947.
39. Steele, G., Jr.; Ellenberg, S.; Hamming, K. CEA monitoring among patients in multi-institutional adjuvant GI therapy protocols. Ann. Surg. 1982, 796, 162-169.
40. Yeatman, T.J.; Bland, K.I.; Copeland, E.M., III; Hollenbeck, J.I.; Souba, W.W.; Vogel, S.B.; Kimura, A.K. Relationship between colorectal liver metastases and CEA levels in gallbladder bile. Ann. Surg. 1989, 270 (4), 505-512.
41. Paganuzzi, M.; Onetto, M.; de Paoli, M.; Castagnola, M.; de Salvo, L.; Civalleri, D.; Grossi, C.E. Carcinoembryonic antigen (CEA) in serum and bile of colorectal cancer patients with or without detectable liver metastases. Anticancer Res. 1994, 74 (3B), 1409-1412.
42. Frikart, L.; Fournier, K.; Mach, J.P.; Givel, J.C. Potential value of biliary CEA assay in early detection of colorectal adenocarcinoma liver metastases. Eur. J. Surg. Oncol. 1995, 21 (3), 276-279.
43. Novell, F.; Trias, M.; Molina, R.; Filella, X. Detection of occult liver metastases in colorectal cancer by measurement of biliary carcinoembryonic antigen. Anticancer Res. 1997, 77 (4A), 2743-2746.
44. Paul, M.A.; Visser, J.J.; Mulder, C.; Blomjous, J.G.; van Kamp, G.J.; Cuesta, M.A.; Meijer, S. Detection of occult liver metastases by measurement of biliary carcinoembryonic antigen concentrations. Eur. J. Surg. 1996, 762 (6), 483-488.
45. Paul, M.A.; Visser, J.J.; Mulder, C.; van Kamp, G.J.; Cuesta, M.A.; Meijer, S. The use of biliary CEA measurements in the diagnosis of recurrent colorectal cancer. Eur. J. Surg. Oncol. 1997, 23 (5), 419-423.
46. Gabauer, G.; Muller-Buchholtz, W. CEA and CA 19-9: implications of quantitative marker measurements in tissues for prognosis of colorectal cancer. Cancer Dis. Prev. 2001, 23 (4), 344-351.
47. Eskelinen, M.; Pasanen, P.; Kulju, A.; Janatuinen, E.; Miettinen, P.; Poikolainen, E.; Tarvainen, R.; Nuutinen, P.; Paakkonen, M.; Alhava, E. Clinical evaluation of serum tumor markers CEA, CA 50 and CA 242 in colorectal cancer. Anticancer Res. 1994, 74 (3b), 1427-1432.
48. Wanebo, H.J.; Rao, B.; Pinsky, C.M.; Hoffman, R.G.; Steams, M.; Schwanz, M.K.; Oettgen, H.G. The use of the preoperative carcinoembryonic antigen level as a prognostic indicator to complement pathologic staging. N. Engl. J. Med. 1978, 299 (9), 448-451.
49. Stevens, D.P.; MacKay, I.R.; Cullen, K.J. Carcinoembryonic antigen in an unselected elderly population: a four year follow-up. Br. J. Cancer 1975, 32, 147-152.
50. Cullen, K.J.; Stevens, D.P.; Frost, M.A.; MacKay, I.R. CEA, smoking, and cancer in a longitudinal population study. Aust. N. Z. J. Med. 1976, 6 (4), 279-283.
51. Anonymous. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology. J. Clin. Oncol. 1996, 74 (10), 2843-2877.
52. Ladenson, J.H.; McDonald, J.M.; Landt, M.; Schwartz, M.K. Colorectal carcinoma and carcinoembryonic antigen (CEA). Clin. Chem. 1980, 26 (8), 1213-1220.
53. Staab, H.J.; Anderer, F.A.; Stumpf, E.; Hornung, A.; Fischer, R.; Kieninger, G. Eighty-four potential second-look operations based on sequential carcinoembryonic antigen determinations and clinical investigations in patients with recurrent gastrointestinal cancer. Am. J. Surg. 1985, 749 (2), 198-204.
54. Ballesta, A.M.; Molina, R.; Filella, X.; Jo, J.; Gimenez, N. Carcinoembryonic antigen in staging and follow-up of patients with solid tumors. Tumour Biol. 1995, 16 (1), 32-41.
55. Hansen, H.J.; Snyder, J.J.; Miller, E.; Vanderwoorde, J.P.; Miller, O.N.; Mines, L.R.; Burns, J.J. Carcinoembryonic antigen (CEA) assay. A laboratory adjunct in the diagnosis and management of cancer. Human Pathol. 1974, 5 (2), 139-147.
56. Wolmark, N.; Fisher, B.; Wieand, H.S.; Henry, R.S.; Lerner, H.; Legault-Poissons, S.; Deckers, P.J.; Dimitrov, N.; Gordon, P.H.; Jochimsen, P.; Oishi, N. The prognostic significance of preoperative Carcinoembryonic antigen levels on colorectal cancer. Results from NSABP clinical trials. Ann. Surg. 1984, 799 (4), 375-382.
57. Jessup, J.; Thomas, P. Carcinoembryonic antigen: function in metastasis by human colorectal carcinoma. Cancer Metastasis Rev. 1984, 8, 263-280.
58. Slentz, K.; Senagore, A.; Hibbert, J.; Mazier, W.P.; Talbott, T.M. Can Preoperative and postoperative CEA predict survival after colon cancer resection? Am. Surg. 1994, 60 (7), 528-532.
59. Wichmann, M.W. Results of long-term follow-up after resection of Dukes' A colorectal cancer. World J. Surg. 2002, 26 (6), 732-736.
60. Reiter, W.; Stieber, P.; Reuter, L.; Nagel, D.; Lau-Werner, U.; Lamerz, R. Multivariate analysis of the prognosis value of CEA and CA 19-9 serum levels in colorectal cancer. Anticancer Res. 2000, 20 (6D), 5195-5198.
61. Louhimo, J.; Carpelan-Holmstrom, M.; Alfthan, H.; Stenman, U.H.; Jarvinen, H.J.; Haglund, C. Serum HCG-beta, CA 72-4, and CEA are independent prognostic factors in colorectal cancer. Int. J. Cancer 2002, 101; (6), 545-548.
62. Compton, C.C.; Fielding, L.P.; Burgart, L.J.; Conley, B.; Cooper, H.S.; Hamilton, S.R.; Hammond, M.E.; Henson, D.E.; Hutter, R.N.; Nagle, R.B.; Nielsen, M.L.; Sargent, D.J.; Taylor, C.R.; Welton, M.; Willett, C. Prognostic factors in colorectal cancer, College of American Pathologists Consensus Statement 1999. Arch. Pathol. Lab. Med. 2000, 724 (7), 979-994.
63. Zamcheck, N. The present status of Carcinoembryonic antigen (CEA) in diagnosis, detection of recurrence, prognosis, and evaluation of therapy of colon and pancreatic cancer. Clin. Gastroenterol. 1976, 5 (3), 625-638.
64. Filella, X.; Molina, R.; Pique, J.M.; Grauss, J.J.; Garcia-Valdenasas, J.C.; Biete, A.; Novell, F.; Astudillo, E.; Bordas, J.M.; Campo, E.; de Lacy, A.; Daniels, M.; Ballesta, A.M. CEA as a prognostic factor in colorectal cancer. Anticancer Res. 1994, 74 (2B), 705-708.
65. Wiratkapun, S.; Kraemer, M.; Seow-Choen, F.; Ho, Y.H.; Euk, W. High preoperative serum CEA predicts metastatic recurrence in potentially curable colon cancer. Dis. Colon Rectum 2001, 44 (2), 231-235.
66. Nakamura, T.; Tabuchi, Y.; Nakae, S.; Ohno, M.; Saitoh, Y. Serum Carcinoembryonic antigen levels and proliferating cell nuclear antigen labeling index for patients with colorectal carcinoma. Cancer 1996, 77 (8 Suppl.), 1741-1746.
67. Carriquiry, L.; Pineyro, A. Should CEA be used in the management of patients with colorectal cancer? Dis. Colon Rectum 1999, 42 (7), 921-929.
68. Arnaud, J.P.; Koehl, C.; Adloff, M. Carcinoembryonic antigen (CEA) in diagnosis and prognosis of colorectal carcinoma. Dis. Colon Rectum 1980,23 (3), 141-144.
69. Abad, A.; Font, A.; Pinol, M. Analysis of the clinical prognostic factors in colorectal cancer patients undergoing curative resection. Proc. Am. Soc. Clin. Oncol. 1993, 72, 693a.
70. Boey, J.; Cheung, H.C.; Lai, C.K.; Wong, J. A prospective evaluation of serum Carcinoembryonic antigen (CEA) levels in the management of colorectal carcinoma. World J. Surg. 1984, 8(3), 279-286.
71. Mayer, R.J.; Gamick, M.B.; Steele, G.P.; Zameheck, N. Carcinoembryonic antigen (CEA) as a monitor of chemotherapy in disseminated colorectal cancer. Cancer 1978, 42 (Suppl. 3), 1428-1433.
72. Glover, C.; Douse, P.; Kane, P.; Karani, J.; Meire, H.; Mohummadtaghi, S.; Allen-Mersh, T.G. Accuracy of investigation for asymptomatic colorectal liver metastases. Dis. Colon Rectum 2002, 45 (4), 476-484.
73. Sugarbaker, P.H.; Gianola, F.J.; Dwyer, A. A simplified plan for follow up of patients with colon and rectal cancer supported by prospective studies of laboratory and radiologic test results. Surgery 1987, 702, 79-87.
74. Rocklin, M.S.; Sengore, A.J.; Talbott, T.M. Role of carcinoembryonic antigen and liver function tests in the detection of recurrent colorectal carcinoma. Dis. Colon Rectum 1991, 34, 794-797.
75. Filella, X.; Molina, R.; Pique, J.M.; Garcia-Valdecasas, J.C.; Grau, J.J.; Novell, F.; Astudillo, E.; de Lacy, A.; Daniels, M.L.; Ballesta, A.M. Use of CA 19-9 in the early detection of recurrences in colorectal cancer: comparison with CEA. Tumour Biol. 1994, 15 (1), 1-6.
76. Hall, N.R.; Pinan, P.G.; Stephenson, B.M.; Purves, D.A.; Cooper, E.H. The role of CA-242 and CEA in surveillance following curative resection for colorectal cancer. Br. J. Cancer 1994, 70 (3), 549-553.
77. Martin, E.W.; Minton, J.P.; Carey, L.C. CEA-directed second-look surgery in the asymptomatic patient after primary resection of colorectal carcinoma. Ann. Surg. 1983, 202, 310-317.
78. Allen-Mersh, T.G. Aspects of treatment. Serum CEA in the follow-up of colorectal carcinoma. Experience in a District General Hospital. Ann. L. Coll. Surg. Eng. 1984, 66, 751-755.
79. Makela, J.T.; Laitinen, S.O.; Kairaluoma, M.I. Five year followup after radical surgery for colorectal cancer - results of a prospective randomized trial. Arch. Surg. 1995, 130, 1062-1067.
80. Lucha, P.A., Jr.; Rosen, L.; Olenwine, J.A.; Reed, J.F., III; Riether, R.D.; Stasik, J.J., Jr.; Khubehandani, I.T. Value of carcinoembryonic antigen monitoring in curative surgery for recurrent colorectal carcinoma. Dis. Colon Rectum 1997, 40 (2), 145-149.
81. Miles, W.F.; Greig, J.D.; Seth, J.; Sturgeon, C.; Nixon, S.J. Raised carcinoembryonic antigen level as an indicator of recurrent disease in follow up of patients with colorectal cancer. Br. J. Gen. Pract. 1995, 45 (395), 287-288.
82. Minton, J.P.; Hoehn, J.L.; Gerber, D.M. Results of a 400 patient carcinoembryonic antigen second-look colorectal cancer study. Cancer 1986, 55, 1284-1290.
83. Bruinvels, D.J.; Stiggelbout, A.M.; Kievit, J.; van Houwelingen, H.C.; Habbema, J.D.; van de Velde, C.J. Follow up of patients with colorectal cancer. Ann. Surg. 1994, 279 (2), 174-182.
84. Berman, J.M.; Cheung, R.J.; Weinberg, D.S. Surveillance after colorectal cancer resection. Lancet 2000, 355, 395-399.
85. Klevit, J.; van de Velde, C.J. Utility and cost of carcinoembryonic antigen monitoring in colon cancer follow-up evaluation: a Markov analysis. Cancer 1990, 65, 2580-2587.
86. Behbehani, A.I.; al-Naqeeb, N.; Omar, Y.T.; el-Nas, S.A.; al-Deen, A.S.; Awwad, A.; al-Jazzaf, H.; Nasralla, M.Y.; Szymedrea, J.J. Serial determinations of serum CEA in monitoring management of patients with colorectal carcinoma. Oncology 1990, 47 (4), 303-307.
87. Staab, H.J.; Anderer, F.A.; Hornung, A.; Stumpf, E.; Fischer, R. Doubling time of circulating CEA and its relation to survival of patients with recurrent colorectal cancer. Br. J. Cancer 1982, 46 (5), 773-781.
88. Beart, R.; Metzger, P.; O'Connell, M.; Schutt, A. Postoperative screening of patients with carcinoma of the colon. Dis. Colon Rectum 1981, 24, 585-589.
89. Graham, R.A. Postsurgical surveillance of colon cancer - preliminary cost analysis of physician examination, CEA testing, chest xray, and colonoscopy. Ann. Surg. 1998, 228 (1), 59-63.
90. Fletcher, R.H. CEA monitoring after surgery for colorectal cancer: when is the evidence sufficient. JAMA 1993, 270, 987-988.
91. Seregni, E.; Bombardieri, E.; Bogni, A.; Crippa, F.; De Jager, E.; Buraggi, G.E. The role of the serum carcinoembryonic antigen (CEA) in the management of patients with colorectal carcinoma: the experience of the institute tumori of Milan. Int. J. Biol. Markers 1992, 7 (3), 167-170.
92. McCall, J.; Black, R.B.; Rich, C.A.; Harvey, J.R.; Baker, R.A.; Watts, J.M.; Toouli, J. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis. Colon Rectum 1994, 37 (9), 875-881.
93. Staab, H.J.; Anderer, F.A.; Stumpf, E.; Fischer, R. Slope analysis of postoperative CEA time course and its possible application as an aid in diagnosis of disease progression in gastrointestinal cancer. Am. J. Surg. 1978, 136, 322-327.
94. Carl, J.; Bentzen, S.M.; Norgaard-Pederson, B.; Kronberg, O. Modelling of serial carcinoembryonic antigen changes in colorectal cancer. Scand. J. Clin. Lab. Invest. 1993, 53, 751-755.
95. Umehara, Y.; Kimura, R.; Yoshida, M.; Oba, N.; Harada, Y. Comparison of doubling times of serum carcinoembryonic antigen produced by various metastatic lesions in recurrent gastric and colorectal carcinomas. Cancer 1993, 71, 4055-4059.
96. Kimura, O.; Kaibara, N.; Nishidoi, H.; Okamoto, T.; Takebayashi, M.; Kawasumi, H.; Koga, S. Carcinoembryonic antigen slope as an early indicator for recurrence of colorectal carcinoma. Jpn. J. Surg. 1986, 16 (2), 106-111.
97. Desch, C.E.; Benson, A.B., III; Smith, T.J.; Flynn, P.J.; Krause, C.; Loprinzi, C.L.; Minsky, B.D.; Petrelli, N.J.; Pfister, D.G.; Somerfield, M.R. Recommended colorectal cancer surveillance guidelines by the american society of clinical oncology. J. Clin. Oncol. 1999, 77 (4), 1312-1321.
98. Strangl, R.; Altendorf-Hoffman, A.; Chamley, R.; Scheele, J. Factors influencing the natural history of colorectal liver metastases. Lancet 1994, 343, 1405-1410.
99. Hohenberger, P.; Schlag, P.; Gerneth, T.; Herfath, C. Pre and post operative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases. Predictive value and implications for adjuvant treatment based on multivariate analysis. Ann. Surg. 1994, 279, 135-143.
100. Ishizuka, D.; Shirai, Y.; Sakai, Y.; Hatakeyama, K. Colorectal carcinoma liver metastases: clinical significance of preoperative measurement of serum CEA and carbohydrate antigen 19-9 levels. Int. J. Colorectal Dis. 2001, 16 (1), 32-37.
101. Gervaz, P.; Blanchard, A.; Pampallona, S.; Mach, J.P.; Fontolliet, C.; Gillet, M. Postoperative CEA concentration after hepatic resection. Eur. J. Surg. 2000, 166 (7), 557-561.
102. Preketes, A.; King, J.; Caplehorn, J.; Clingan, P.; Ross, W.; Morris, D. CEA reduction after cryotherapy for liver metastases from colon cancer predicts survival. Aust. N. Z. J. Surg. 1994, 64, 612-614.
103. Rena, O.; Casadio, C.; Viano, F.; Cristofori, R.; Ruffini, P.L.; Maggi, G. Pulmonary resection for metastases from colorectal cancer: factors influencing prognosis. A twenty year experience. Eur. J. Cardio-Thorac. Surg. 2002, 21 (5), 906-912.
104. Sakamoto, T.; Tsubota, N.; Iwonaga, K.; Yuki, T.; Matsuoka, H.; Yoshimura, M. Pulmonary resection for metastases from colorectal cancer. Chest 2001, 119 (4), 1069-1072.
105. Saito, Y.; Omiya, H.; Kohno, K.; Kobayashi, T.; Itoi, K.; Teramachi, M.; Sasaki, M.; Suzuki, H.; Takao, H.; Nakade, M. Pulmonary metastatectomy for 165 patients with colorectal carcinoma: a prognostic assessment. J. Thorac. Cardiovasc. Surg. 2002, 724 (5), 1007-1013.
106. Zink, S.; Kayser, G.; Gabius, H.J.; Kayser, K. Survival, disease-free interval and associated tumor features in patients with colorectal carcinoma and their resected intra-pulmonary metastases. Eur. J. Cardio-Thorac. Surg. 2001, 79 (6), 908-913.
107. Scars, H.; Shen, J.; Herlyn, M.; Atkinson, B.; Engstom, P.; Koprowski, H. Circulating tumor markers and assessment of response to intrahepatic chemotherapy of colon carcinoma. Am. J. Clin. Oncol. 1985, 8(2), 108-117.
108. Barone, C.; Astone, A.; Cassano, A.; Garufi, C.; Astone, P.; Grieco, Á.; Noviello, M.R.; Ricevuto, E.; Albanese, C.; Gambassi, G. Advanced colon cancer: staging and prognosis by CEA test. Oncology 1990, 47 (2), 128-132.
109. Carl, J.; Brunsgaard, N.; Kjaer, M.; Norgaard-Pederson, B. Estimated treatment responses in metastatic colorectal carcinoma based on longitudinal carcinoembryonic antigen scries. Scand. J. Clin. Lab. Invest. 1993, 53, 829-834.
110. Quentmeier, A.; Schlag, P.; Hohenberger, P.; Schwarz, V.; Abel, U. Assessment of serial carcinoembryonic antigen. Determinations to monitor the therapeutic progress and prognosis of metastatic liver disease treated by regional chemotherapy. J. Surg. Oncol. 1989, 40 (2), 112-118.
111. Herrera, M.A.; Chu, T.M.; Holyoke, E.D.; Mittleman, A. CEA monitoring of palliative treatment for colorectal carcinoma. Ann. Surg. 1977. 185, 23-30.
112. Shani, A.; O'Connell, M.J.; Moertel, C.G.; Schmitt, A.J.; Silvers, A.; Go, V.L. Serial plasma carcinoembryonic antigen measurements in the management of metastatic colorectal carcinoma. Ann. Intern. Med. 1978. 88 (5), 627-630.
113. Ward, U.; Primrose, J.N.; Finan, P.J.; Perren, T.J.; Selby, P.; Purves, D.A.; Cooper, E.H. The Use of tumour markers CEA, CA-195 and CA-242 in evaluating the response to chemotherapy in patients with advanced colorectal cancer. Br. J. Cancer 1993, 67 (5), 1132-1135.
114. Wang, W.S.; Lin, J.K.; Lin, T.C.; Chiou, T.J.; Liu, J.H.; Fan, P.S.; Yen, C.C.; Chen, W.S.; Jiang, J.K.; Yang, S.H.; Wang, H.S.; Chen, P.M. Carcinoembryonic antigen in monitoring of response to systemic chemotherapy in patients with metastatic colorectal cancer. Int. J. Colorectal Dis. 2001, 16 (2), 96-101.
115. Buroker, T.R.; O'Connell, M.J.; Wieand, H.S.; Krook, J.E.; Gerstner, J.B.; Mailliard, J.A.; Schaefer, P.L.; Levitt, R.; Kardinal, C.G.; Gesme, D.H., Jr. Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer. J. Clin. Oncol. 1994, 72 (1), 14-20.
116. Glimelius, B. Biochemical modulation of 5-fluorouracil: a randomized comparison of sequential methotrexate, 5-fluorouracil and leucovorin in patients with advanced symptomatic colorectal cancer. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Ann. Oncol. 1993, 3, 235-240.
117. Figueras, J.; Valls, C.; Rafecas, A.; Fabregat, J.; Ramos, E.; Jaurrieta, E. Resection rate and effect of postoperative chemotherapy on survival after surgery for colorectal liver metastases. Br. J. Surg. 2001, 88 (7), 980-985.
118. Rothenberg, M.L.; Cox, J.V.; DeVore, R.F.; Hainsworth, J.D.; Pazdur, R.; Rivkin, S.E.; Macdonald, J.S.; Geyer, C.E., Jr.; Sandback, J.; Wolf, D.L.; Mohrland, J.S.; Elfring, G.L.; Miller, L.L.; von Hoff, D.D. A multicenter, phase II trial of weekly irinotecan (CPT-11 ) in patients with previously treated colorectal carcinoma. Cancer 1999, 85 (4), 786-795.
119. Patt, Y.Z.; Podoloff, D.A.; Curley, S.; Kasi, L.; Smith, R.; Bhadkamkar, V.; Chamsangavej, C. Technetium 99m-labelled IMMU-4, a monoclonal antibody against CEA, for imaging of occult recurrent colorectal cancer in patients with rising serum CEA levels. J. Clin. Oncol. 1994, 72 (3), 489-495.
120. Moffat, F.L., Jr.; Pinsky, C.M.; Hammershaimb, L.; Petrelli, N.J.; Patt, Y.Z.; Whaley, F.S.; Goldenberg, D.M. Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. J. Clin. Oncol. 1996, 14 (8), 2295-2305.
121. von Mehren, M.; Arlen, P.; Tsang, K.Y.; Rogatko, A.; Meropol, N.; Cooper, H.S.; Davey, M.; McLaughlin, S.; Schlom, J.; Weiner, L.M. Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7.1 transgenes in patients with recurrent CEA-expressing adenocarcinomas. Clin. Cancer Res. 2000, 6 (6), 2219-2228.
122. Foon, K.A.; Chakraborty, M.; John, W.J.; Sherratt, A.; Kohler, H.; Bhattacharya-Chatterjee, M. Immune response to the carcinoembryonic antigen in patients treated with an anti-idiotype antibody vaccine. J. Clin. Invest. 1995, 96 (1), 334-342.
123. Conry, R.M.; Curiel, D.T.; Strong, T.V.; Moore, S.E.; Allen, K.O.; Barlow, D.L.; Shaw, D.R.; LoBuglio, A.F. Safety and immunogenicity of a DNA vaccine encoding CEA and hepatitis B surface antigen in colorectal carcinoma patients. Clin. Cancer Res. 2002, 8 (9), 2782-2787.
124. Shively, J.E.; Beatty, J.D. CEA-related antigens: molecular biology and clinical significance. CRC Crit. Rev. Oncol./Hematol. 1985, 2, 355-399.
125. Rogers, G.T. Carcinoembryonic antigens and related glycoproteins. Molecular aspects and specificity. Biochem. Biophys. Acta 1983, 695, 227-249.
126. Thompson, J.; Zimmerman, W. The carcinoembryonic antigen gene superfamily: structure, expression, and evolution. Tumor Biol. 1988, 9, 63-83.
127. Primus, F.J.; Newman, E.S.; Hansen, H.J. Affinity in radioimmunoassay of antibody cross reactive with carcinoembryonic antigen (CEA) and colon carcinoma antigen-III (CCA-III). J. Immunol. 1977, 115, 55-61.
128. Rosai, J.; Tillack, T.W.; Marchesi, V.T. Membrane antigens of human colonie carcinoma and non-tumoral colonie mucosa: results obtained with a new isolation method. Int. J. Cancer 1972, 10, 357-367.
129. Shively, J.E.; Todd, C.W.; Go, V.L.; Egan, M.L. Amino-terminal sequence of a carcinoembryonic antigen-like glycoprotein isolated from the colonie lavages of healthy individuals. Cancer Res. 1978, 38 (3), 503-505.
130. Van Nagell, J.R., Jr.; Donaldson, E.S.; Gay, E.C.; Sharkey, R.M.; Rayburn, P.; Goldenberg, D.M. Carcinoembryonic antigen in ovarian epithelial cystadenocarcinomas: the prognostic value of tumor and serial plasma determinations. Cancer 1978, 41 (6), 2335-2340.
131. Walstrom, T.; Lindgren, J.; Korhonen, M.; Seppala, M. Distinction between endocervical and endometrial adenocarcinoma with immunoperoxidase staining of carcinoembryonic antigen in routine staining of carcinoembryonic antigen in routine histological tissue specimens. Lancet 1979, 2 (8153), 1159-1160.
132. Nakamura, T. Serum CEA levels and proliferating cell nuclear antigen labeling index for patients with colorectal carcinoma. Correlation with tumor progression and survival. Cancer 1996, 77 (8 Suppl. 1), 1741-1746.
133. Goslin, R.; O'Brien, M.J.; Steele, G. Correlation of plasma CEA and CEA tissue staining in poorly colorectal cancer. Am. J. Med. 1981, 71, 246-249.
134. Constanza, M.E.; Das, S.; Nathanson, L.; Rule, A.; Schwartz, R.S. Proceedings: carcinonembryonic antigen. Report of a screening study. Cancer 1974, 33 (2), 583-590.
135. Wichmann, M.W.; Lau-Werner, U.; Muller, C.; Hornung, H.M.; Stieber, P.; Shildberg, F.W. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer. Anticancer Res. 2000, 20 (6D), 4953-4956.
136. van der Schouw, Y.T.; Verbeek, A.L.; Woobes, T.; Segers, M.F.; Thomas, C.M. Comparison of four serum tumour markers in the diagnosis of colorectal carcinoma. Br. J. Surg. 1992, 66 (1), 148-154.
137. Yamaguchi, Y.; Kurosaka, Y.; Ishida, T.; Nishimura, G.; Kanno, M.; Kosaka, T.; Yonemura, Y.; Miyazaki, I. Clinical significance of tumor marker NCC-ST 439 in large bowel cancers. Dis. Colon Rectum 1991, 34 (10), 921-924.
138. Evans, J.T.; Mittelman, A.; Chu, M.; Holyoke, E.D. Pre- and postoperative uses of CEA. Cancer 1978, 42 (3 Suppl. 1), 1419-1421.
139. Chu, D.Z.; Erickson, C.A.; Russell, M.P.; Thompson, C.; Lang, N.P.; Broadwater, R.J.; Westbrook, K.C. Prognostic significance of carcinoembryonic antigen in colorectal carcinoma. Arch. Surg. 1991, 726 (3), 314-316.
140. Onetto, M.; Paganuzzi, M.; Secco, G.B.; Fardelli, R.; Santi, F.; Rovida, J.; Ferrara, G.E. Preoperative carcinoembryonic antigen and prognosis in patients with colorectal cancer. Biomed. Pharmacother. 1985, 39 (7), 392-395.
141. Stahle, E.; Glimellus, B.; Bertstrom, R.; Pahlman, L. Preoperative serum markers in carcinoma of the rectum and reectosigmoid. Eur. J. Surg. Oncol. 1988, 14 (4), 287-296.
142. Brummendorf, T.; Anderer, F.; Staab, H.J.; Hornung, A.; Stumpf, E.; Kieninger, G. Prognostic value of preoperative serum CEA level compared to clinical staging: III. An approach to scoring of prognostic factors in colorectal cancer. J. Surg. Oncol. 1985, 23 (4), 263-269.
143. Kohler, J.P.; Simonowitz, D.; Paloyan, D. Preoperative CEA level: a prognostic test in patients with colorectal carcinoma. Am. Surg. 1980, 46,449-452.
144. Lunde, O.; Havig, O. Clinical significance of carcinoembryonic antigen (CEA) in patients with adenocarcinoma in colon and rectum. Acta Chir. Scand. 1982, 148, 189-193.
145. Tartter, P.I.; Slater, G.; Gelernt, I.; Aufses, A.M., Jr. Screening for liver metastases from colorectal cancer with carcinoembryonic antigen and alkaline phosphatasc. Ann. Surg. 1981, 193, 353-359.
146. Tomoda, H.; Furusawa, M. The usefulness and limitations of CEA assay in the management of colorectal cancer. Jpn. J. Surg. 1981, 11, 33-38.
147. Persijn, J.P.; Hart, A.M. Prognostic significance of CEA in colorectal cancer: a statistical study. Clinical evaluation of carcinoembryonic antigen. J. Clin. Chem. Clin. Biochem. 1981, 19, 1117-1123.
148. Kouri, M.; Pyrhonen, S.; Mecklin, J.P.; Jarvinen, H.; Laasonen, A.; Franssila, K.; Kuusela, P.; Nordling, S. Serum carcinoembryonic antigen and DNA ploidy in colorectal carcinoma. Scand. J. Gastroenterol. 1991, 26 (8), 812-818.
149. Bentzen, S.M.; Balslev, I.; Pedersen, M.; Teglbjaerg, P.S.; Hanberg-Soerensen, F.; Bone, J.; Jacobsen, N.O.; Overgaard, J.; Sell, A.; Bertelsen, K.; Hage, E.; Fenger, C.; Kronberg, O.; Hansen, L.; Hoestrup, H.; Noergaard-Pedersen, B. A regression analysis of prognostic factors after resection of Dukes' B and C carcinoma of the rectum and rectosigmoid. Does post-operative CEA change the prognosis? Br. J. Cancer 1988, 58 (2), 195-201.
150. Fucini, C.; Tommasi, M.S.; Cardona, G.; Malatantis, G.; Panichi, S.; Bettini, U. Limitations of CEA monitoring as a guide to second-look surgery in colorectal cancer follow-up. Tumori 1983, 69 (4), 359-364.
151. Szymendera, J.J.; Nowacki, M.P.; Kozlowica-Gudzinska, I.; Kowalska, M. Value of serum levels of carcinoembryonic antigen, CEA, and gastrointestinal cancer antigen, GICA or CA 19-9, for preoperative staging and postoperative monitoring of patients with colorectal carcinoma. Dis. Colon Rectum 1985, 28 (12), 895-899.
152. Bohm, B.; Schwenk, W.; Hucke, H.P.; Stock, W. Does methodic longterm follow-up affect survival after curative resection of colorectal carcinoma? Dis. Colon Rectum 1993, 36 (3), 280-286.
153. Mcling, G.I.; Rognum, T.O.; Clausen, O.P.; Bormer, O.; Lunde, O.C.; Schlichting, E.; Gruner, O.P.; Hognestad, J.; Trondsen, E.; Havig, O.; Bergan, A. Serum carcinoembryonic antigen in relation to survival, DNA ploidy pattern, and recurrent disease in 406 colorectal carcinoma patients. Scand. J. Gastroenterol. 1992, 27 (12), 1061-1068.
154. Wang, J.Y.; Tang, R.; Chiang, J.M. Value of carcinoembryonic antigen in the management of colorectal cancer. Dis. Colon Rectum 1994, 37, 272-277.
155. Albe, X.; Vassilako, P.; Helfer-Guamori, K.; Givel, J.C.; de Quay, N.; Suarder, L.; Eliason, J.F.; Odarehenko, N. Independent prognostic value of ploidy in colorectal cancer: a prospective study using image cytometry. Cancer 1990, 66 (6), 1167-1175.
156. Lim, C.N.; McPherson, T.A.; McClelland, A.R.; McCoy, L.; Koch, M. Value of serial CEA determinations in a surgical adjuvant trial of colorectal and gastric carcinoma. J. Surg. Oncol. 1980, 74 (3), 275-280.
157. Steele, G.; Zamcheck, N.; Wilson, R.; Mayer, R.; Lokich, J.; Rau, P.; Maltz, J. Results of CEA-initiated second-look surgery for recurrent colorectal cancer. Am. J. Surg. 1980, 139 (4), 544-549.
158. Mariani, G.; Carmellini, M.; Bonaguidi, F.; Benelli, M.A.; Toni, M.G. Serum CEA monitoring in the follow-up of colorectal cancer patients with negative preoperative serum CEA. Eur. J. Cancer 1980, 16 (8), 1099-1103.
159. Wood, C.B.; Rateliffe, J.G.; Burt, R.W.; Malcolm, A.J.; Blumgart, L.H. The clinical significance of the pattern of elevated serum carcinoembryonic antigen (CEA) levels in recurrent colorectal cancer. Br. J. Surg. 1980, 67(1), 46-48.
160. Mach, J.P.; Vienny, H.; Jaeger, P.; Haldemann, B.; Egely, R.; Pettavel, J. Long-term followup of colorectal carcinoma patients by repeated CEA radioimmunoassay. Cancer 1978, 42 (Suppl. 3), 1439-1447.
161. Carlsson, U.; Stewonius, J.; Ekelund, G.; Leandoer, L.; Nosslin, B. Is CEA analysis of value in screening for recurrences after surgery for colorectal carcinoma? Dis. Colon Rectum 1983, 26 (6), 369-373.
162. Attiych, F.F.; Stearns, M.W. Second-look laparotomy based on CEA elevations in colorectal cancer. Cancer 1981, 47, 2119-2125.
163. O'Dwyer, P.J.; Mojzisik, C.; McCabe, D.P.; Farrar, W.B.; Carey, L.C.; Martin, E.W., Jr. Reoperation directed by carcinoembryonic antigen level: the importance of a thorough preoperative evaluation. Am. J. Surg. 1988, 155 (2), 227-231.
164. Graffner, H.; Hultberg, B.; Johannsson, B.; Moller, T.; Petersson, B.G. Detection of recurrent cancer of the colon and rectum. J. Surg.Oncol. 1985, 28 (2), 156-159.
165. Tate, H. Plasma CEA in the post-surgical monitoring of colorectal carcinoma. Br. J. Cancer 1982, 46, 323-330.
166. Koch, M.; Washer, G.; Gaedke, H.; McPherson, T.A. Carcinoembryonic antigen: usefulness as a postsurgical method in the detection of recurrence in Dukes' stages B2 and C colorectal cancers. J. Natl. Cancer Inst. 1982, 69 (4), 813-815.
167. Fucini, C.; Tommasi, S.M.; Rosi, S. Follow-up of colorectal cancer resected for cure. Dis. Colon Rectum 1987, 30, 273-277.
168. Sandler, R.S.; Freund, D.A.; Herbst, C.A., Jr.; Sandler, D.P. Cost effectiveness of postoperative carcinoembryonic antigen monitoring in colorectal cancer. Cancer 1984, 53 (1), 193-198.
169. Hine, K.R.; Dykes, P.W. Serum CEA testing in the post-operative surveillance of colorectal carcinoma. Br. J. Cancer 1984, 49, 689-693.
170. Kemeny, M.M.; Sugarbaker, P.H.; Smith, T.J.; Edwards, B.K.; Shawker, T.; Vermess, M.; Jones, A.E. A prospective analysis of laboratory tests and imaging to detect hepatic lesions. Ann. Surg. 1982, 195 (2), 163-167.
171. Moertel, C.G.; Schutt, A.J.; Go, L.W. Carcinoembryonic antigen test for recurrent colorcctal cancer. JAMA 1978, 239, 1065-1066.
172. Steele, J.; Stangl, R.; Altendorf-Hoffman, A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br. J. Surg. 1990, 77, 1241-1246.
173. Morris, D.L.; Ross, W.B. Australian experience of cryoablation of liver tumors: metastases. Surg. Oncol. Clin. N. Am. 1995, 5 (2), 391-397.
174. Goldenberg, D.M. Carcinoembryonic antigen: its role as a marker in the management of cancer: a National Institutes of Health Consensus Development Conference. Ann. Intern. Med. 1981, 94, 407-409.
175. Atkins, C.D. Guidelines for the use of Carcinoembryonic antigen in colorectal cancer (letter; comment). J. Clin. Oncol. 1997, 15, 863-864.
176. Carpelan-Holmstrom, M.; Haglund, C.; Lundin, J.; Alfthan, H.; Stenman, U.H.; Roberts, P.J. Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotropin beta, but not of Carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer. Br. J. Cancer 1996, 74 (6), 925-929.
177. Guthrie, T.H. Carcinoembryonic antigen: the old dog finally learns new tricks (editorial; comment). Dig. Dis. 1996, 74, 1-4.
178. Hida, J.; Yasutomi, M.; Shindoh, K.; Kitauka, M.; Pujimoto, K.; Ieda, S.; Machidera, N.; Kubo, R.; Morikawa, E.; Inufusa, H.; Watatani, M.; Okuno, K. Second-look operation for recurrent colorectal cancer based on Carcinoembryonic antigen and imaging techniques. Dis. Colon Rectum 1996, 39 (1), 74-79.
179. Tobaruela, E.; Enriquez, J.M.; Diez, M.; Camunas, J.; Maguerza, J.; Granell, J. Evaluation of serum Carcinoembryonic antigen monitoring in the follow-up of colorectal cancer patients with metastatic lymph nodes and a normal preoperative serum level. Int. J. Biol. Markers 1997, 72 (1), 18-21.
180. Vauthey, J.N.; Dudrick, P.S.; Lind, D.S.; Copeland, E.M., III. Management of recurrent colorectal cancer: another look at Carcinoembryonic antigen-detected recurrence. Dig. Dis. 1996, 74 (1), 5-13.
181. Wolf, R.F.; Cohen, A.M. The minuscule benefit of serial Carcinoembryonic antigen monitoring after effective curative treatment for primary colorectal cancer. J. Am. Coll. Surg. 1997, 185, 60-64.